2013
DOI: 10.3389/fphar.2013.00113
|View full text |Cite
|
Sign up to set email alerts
|

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(24 citation statements)
references
References 1 publication
0
24
0
Order By: Relevance
“…Although, proprietary drugs may be the outcome of the R & D of some pharmaceutical company or may be the result of a clinical trial of some empirical formula, justifying their promotion, it also proposes a monopoly on the combination and its marketing. It is for this reason, such products are often irrationally priced compared to the classical formulations with much similar composition [10]. Sometimes, there are irrational combinations too which do not have an Ayurvedic justification.…”
Section: Discussionmentioning
confidence: 99%
“…Although, proprietary drugs may be the outcome of the R & D of some pharmaceutical company or may be the result of a clinical trial of some empirical formula, justifying their promotion, it also proposes a monopoly on the combination and its marketing. It is for this reason, such products are often irrationally priced compared to the classical formulations with much similar composition [10]. Sometimes, there are irrational combinations too which do not have an Ayurvedic justification.…”
Section: Discussionmentioning
confidence: 99%
“…As a result, at least 80% of prescriptions filled in the US are for generic drugs according to FDA. A number of studies have demonstrated that replacing brand name drugs by generic drugs has no differences 5 . In contrast, adverse drug reaction was reported to be found in some patients during a trail.…”
Section: Introduction:-mentioning
confidence: 99%
“…WHO defines a generic drug as a pharmaceutical product, usually intended to be interchangeable with an innovator product that is manufactured without a license from the innovator company and marketed after the expiry of the patent or other exclusive rights [4,5].…”
Section: Generic Drugmentioning
confidence: 99%